HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael J Quon Selected Research

Pravastatin (Pravachol)

10/2013Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.
6/2013Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.
3/2011Differential metabolic effects of distinct statins.
6/2009Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael J Quon Research Topics

Disease

76Insulin Resistance
01/2020 - 01/2002
17Type 2 Diabetes Mellitus (MODY)
07/2017 - 02/2002
13Inflammation (Inflammations)
12/2017 - 06/2005
13Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2017 - 06/2005
13Hypertension (High Blood Pressure)
07/2017 - 01/2004
12Obesity
12/2017 - 07/2004
12Atherosclerosis
04/2015 - 01/2004
11Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 02/2007
5Hyperlipidemias (Hyperlipidemia)
03/2011 - 08/2004
5Coronary Disease (Coronary Heart Disease)
02/2008 - 06/2005
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2016 - 02/2009
4Coronary Artery Disease (Coronary Atherosclerosis)
04/2010 - 12/2005
4Hyperinsulinism (Hyperinsulinemia)
07/2008 - 01/2002
4Hyperemia
06/2005 - 12/2004
3Hypercholesterolemia
07/2017 - 02/2011
3Hyperglycemia
07/2015 - 02/2007
3Metabolic Diseases (Metabolic Disease)
09/2013 - 03/2011
3Hypertriglyceridemia
02/2012 - 06/2005
3Heart Diseases (Heart Disease)
04/2010 - 12/2005
3Dyslipidemias (Dyslipidemia)
02/2008 - 02/2007
2Infections
12/2017 - 12/2002
2Glucose Intolerance
01/2016 - 07/2015
2Infarction (Infarctions)
09/2009 - 05/2007
2Essential Hypertension
12/2008 - 01/2008
2Thrombosis (Thrombus)
09/2007 - 11/2005
2Neoplasms (Cancer)
02/2003 - 11/2002
1Sepsis (Septicemia)
01/2018
1Acute Coronary Syndrome
01/2018
1Ischemic Stroke
01/2018
1Atrial Fibrillation
01/2018
1Hemorrhage
01/2018
1Ventricular Remodeling
12/2015

Drug/Important Bio-Agent (IBA)

45Insulin (Novolin)FDA Link
01/2020 - 01/2002
29AdiponectinIBA
12/2016 - 12/2004
21Glucose (Dextrose)FDA LinkGeneric
01/2017 - 02/2002
11Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2017 - 05/2005
7Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2016 - 11/2005
6Simvastatin (Zocor)FDA LinkGeneric
07/2012 - 06/2005
6Proteins (Proteins, Gene)FDA Link
07/2012 - 11/2002
5LDL CholesterolIBA
03/2014 - 01/2008
5Fenofibrate (CiL)FDA LinkGeneric
02/2012 - 05/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2009 - 06/2005
4TeaIBA
01/2017 - 05/2007
4Insulin ReceptorIBA
12/2015 - 04/2004
4Vasodilator Agents (Vasodilators)IBA
10/2013 - 08/2005
4Pravastatin (Pravachol)FDA LinkGeneric
10/2013 - 06/2009
4Pharmaceutical PreparationsIBA
10/2013 - 09/2007
4PolyphenolsIBA
09/2013 - 05/2007
4LipidsIBA
07/2012 - 01/2004
4AdipokinesIBA
02/2011 - 06/2007
4candesartanIBA
04/2010 - 02/2006
4Ramipril (Altace)FDA LinkGeneric
04/2010 - 06/2005
4C-Reactive ProteinIBA
06/2009 - 05/2005
3CholesterolIBA
07/2017 - 01/2004
3Lipoproteins (Lipoprotein)IBA
06/2013 - 02/2008
3LeptinIBA
07/2012 - 06/2008
3Messenger RNA (mRNA)IBA
03/2011 - 11/2002
3Atorvastatin (Lipitor)FDA Link
02/2011 - 05/2005
3ApolipoproteinsIBA
03/2010 - 02/2008
3Nonesterified Fatty Acids (NEFA)IBA
03/2009 - 08/2004
3Angiotensin IIIBA
03/2009 - 03/2006
3Fibric Acids (Fibrates)IBA
02/2008 - 05/2005
3Phosphatidylinositols (Phosphatidylinositol)IBA
08/2007 - 12/2002
3Cardiovascular AgentsIBA
02/2007 - 12/2005
3Endothelin-1 (Endothelin 1)IBA
12/2006 - 04/2006
3Insulin Receptor Substrate ProteinsIBA
06/2005 - 12/2002
3Phosphotransferases (Kinase)IBA
06/2005 - 07/2003
3Serine (L-Serine)FDA Link
08/2004 - 12/2002
2Fatty Acids (Saturated Fatty Acids)IBA
12/2017 - 05/2013
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017 - 05/2013
2Interleukin-1 Receptor-Associated KinasesIBA
01/2017 - 06/2005
2Infliximab (Remicade)FDA Link
12/2016 - 07/2008
2CaspasesIBA
11/2015 - 07/2015
2Exenatide (Byetta)FDA Link
10/2014 - 01/2014
2Rosuvastatin Calcium (Crestor)FDA Link
06/2013 - 07/2012
2Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
06/2013 - 03/2011
2Rosiglitazone (Avandia)FDA Link
09/2009 - 12/2006
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
07/2009 - 08/2006
2CytokinesIBA
03/2009 - 07/2008
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
07/2008 - 01/2006
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
07/2008 - 01/2006
2PPAR alphaIBA
02/2008 - 11/2005
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2007 - 01/2002
2EnalaprilFDA LinkGeneric
05/2007 - 12/2006
2CD40 Ligand (CD40L)IBA
03/2007 - 01/2007
2Nitroglycerin (Dynamite)FDA LinkGeneric
03/2007 - 01/2004
2Vasoconstrictor AgentsIBA
12/2006 - 08/2005
22,4-thiazolidinedione (thiazolidinedione)IBA
07/2006 - 08/2003
2PPAR gammaIBA
07/2006 - 08/2003
2Fibrinogen (Factor I)FDA Link
06/2005 - 05/2005
2Malondialdehyde (Propanedial)IBA
06/2005 - 12/2004
1AnticoagulantsIBA
01/2018
1Pathogen-Associated Molecular Pattern MoleculesIBA
12/2017
1Toll-Like Receptor 4IBA
12/2017
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2017
1Estrogens (Estrogen)FDA Link
01/2016
1Estradiol (Delestrogen)FDA LinkGeneric
01/2016
1Letrozole (Femara)FDA LinkGeneric
01/2016

Therapy/Procedure

31Therapeutics
07/2017 - 12/2004
2Microbubbles
12/2008 - 11/2006